Role of high sensitivity C- reactive protein as a marker of inflammation and its prognostic significance in chronic kidney disease patients


  • Sanjeev Kumar Khunte Department of Medicine, AIMS, Raipur, Chhattisgarh, India
  • Jitendra Kumar Department of Medicine, RIMS, Ranchi, Jharkhand, India
  • Prakash Khunte Department of Medicine, Govt. Medical College, Rajnandgaon, Chattisgarh, India



Clinical, ETV, Hydrocephalus, Neuroendoscope


Background: Chronic kidney disease (CKD) is a clinical syndrome due to irreversible renal dysfunction leading to excretory, metabolic and synthetic failure culminating into accumulation of non-protein nitrogenous substances and present with various clinical manifestations. Elevated circulating concentrations of CRP are a common phenomenon in ESRD patients. The prevalence and magnitude of inflammation increases as renal function declines.

Methods: The current cross-sectional observation study was conducted in Rajendra institute of medical sciences, Ranchi during study period October 2015 to September 2017 on admitted patients with chronic kidney disease. 90 patients of different age groups between 16-75 years were enrolled in the study. Samples were selected by using simple random sampling method. Informed consent was obtained from all the patients.

Results: 85.6% of the patients studied were males and 14.4% of the patients were females. Most cases of CKD were associated with hypertension (77.8%) out of which there were 62 males and 8 females, followed by DM (25.5%) where there were 20 males and 3 females. 44.4% cases had an elevated level of hs-CRP (more than 3 mg/L) while 55.6% patients had hs-CRP below 3 mg/l. Out of 40 high hs-CRP patients, 35 were male and 5 were female. Patients with elevated creatinine level had significant high hs-CRP level.

Conclusions: Chronic kidney diseases, Cardiovascular disease, HS-CRP, Inflammation


Harrison’s Manual of Medicines. 18th edition. 2280-2327; 2911-2940.

Barany P. Inflamation, serum C-reactive protein and erythropoiet in resistance. Naphrol Dial Transplant 20001;16:224-7.

Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003 Jun 15;111(12):1805-12.

Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New Eng J Med. 1997 Apr 3;336(14):973-9.

Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New Eng J Med. 2002 Nov 14;347(20):1557-65.

Barrett BJ, Parfrey PS, Morgan J, Barré P, Fine A, Goldstein MB, Handa SP, Jindal KK, Kjellstrand CM, Levin A, Mandin H. Prediction of early death in end-stage renal disease patients starting dialysis. Am J Kidney Dis. 1997 Feb 1;29(2):214-22.

Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003 Jan 7;107(1):87-92.

National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1-S266.

Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Internal Med. 2004 Mar 22;164(6):659-63.

Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005 Feb 1;16(2):489-95.

Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in US adults. Ann Internal Med. 2004 Feb 3;140(3):167-74.

Muntner P, He J, Astor BC, Folsom AR, Coresh J. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the Atherosclerosis Risk in Communities study. J Am Soc Nephrol. 2005;16(2):529-538.

Chhetri PK, Manandhar DN, Bhattarai SP, Pahari LR, Shrestha R. Chronic kidney disease on hemodialysis in Nepal Medical College Teaching Hospital. Department of Medicine, Nepal Medical College Teaching Hospital, Jorpati, Kathmandu, Nepal. Nepal Med Coll J. 2008;10(1):8-10.

Nand N, Aggarwal HK, Yadav RK, Gupta A, Sharma M. Role of high-sensitivity C-reactive Protein as a Marker of Inflammation in pre-dialysis patients of chronic renal failure. JIACM. 2009;10(1):18-22.

Jalal D, Chonchol M, Etgen T, Sander D. C-reactive protein as a predictor of cardiovascular events in elderly patients with chronic kidney disease. J Nephrol. 2012 Sep;25(5):719.

Friedman AN, Hunsicker LG, Selhub J, Bostom AG. C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy. Kidney Int. 2005 Aug 1;68(2):773-8.






Original Research Articles